We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Incentive Programs for Female Substance Abusers Who Smoke - 3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00064922
Recruitment Status : Completed
First Posted : July 16, 2003
Last Update Posted : January 12, 2017
Information provided by:
National Institute on Drug Abuse (NIDA)

Brief Summary:
The purpose of this study is to examine the effects of incentive programs for the treatment of nicotine dependence in women who have problems with substance dependence.

Condition or disease Intervention/treatment Phase
Tobacco Use Disorder Behavioral: Behavior Therapy Phase 2 Phase 3

Detailed Description:
This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Primary Purpose: Treatment
Official Title: Incentive Programs for Female Substance Abusers Who Smoke
Study Start Date : January 2002
Primary Completion Date : April 2006
Study Completion Date : April 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Abuse
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   15 Years to 99 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol
  • Nicotine Dependent as confirmed by DSM-IV checklist
  • Current cigarette smoker
  • Breath CO reading of at least 8 ppm at the time of the initial study screening
  • Current client with the Shields for Families (Shields) treatment programs

Exclusion Criteria:

  • Non-smoker

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00064922

United States, California
Shields for Families, Inc.
Los Angeles, California, United States, 90061
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Principal Investigator: Leslie Amass, Ph.D. Los Angeles Treatment Research Center

ClinicalTrials.gov Identifier: NCT00064922     History of Changes
Other Study ID Numbers: NIDA-13638-3
First Posted: July 16, 2003    Key Record Dates
Last Update Posted: January 12, 2017
Last Verified: May 2008

Keywords provided by National Institute on Drug Abuse (NIDA):
nicotine dependence

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders